Suppr超能文献

食管腺癌扩大经胸切除术与有限经裂孔切除术的比较

Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus.

作者信息

Hulscher Jan B F, van Sandick Johanna W, de Boer Angela G E M, Wijnhoven Bas P L, Tijssen Jan G P, Fockens Paul, Stalmeier Peep F M, ten Kate Fiebo J W, van Dekken Herman, Obertop Huug, Tilanus Hugo W, van Lanschot J Jan B

机构信息

Department of Surgery, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

出版信息

N Engl J Med. 2002 Nov 21;347(21):1662-9. doi: 10.1056/NEJMoa022343.

Abstract

BACKGROUND

Controversy exists about the best surgical treatment for esophageal carcinoma.

METHODS

We randomly assigned 220 patients with adenocarcinoma of the mid-to-distal esophagus or adenocarcinoma of the gastric cardia involving the distal esophagus either to transhiatal esophagectomy or to transthoracic esophagectomy with extended en bloc lymphadenectomy. Principal end points were overall survival and disease-free survival. Early morbidity and mortality, the number of quality-adjusted life-years gained, and cost effectiveness were also determined.

RESULTS

A total of 106 patients were assigned to undergo transhiatal esophagectomy, and 114 to undergo transthoracic esophagectomy. Demographic characteristics and characteristics of the tumor were similar in the two groups. Perioperative morbidity was higher after transthoracic esophagectomy, but there was no significant difference in in-hospital mortality (P=0.45). After a median follow-up of 4.7 years, 142 patients had died--74 (70 percent) after transhiatal resection and 68 (60 percent) after transthoracic resection (P=0.12). Although the difference in survival was not statistically significant, there was a trend toward a survival benefit with the extended approach at five years: disease-free survival was 27 percent in the transhiatal-esophagectomy group, as compared with 39 percent in the transthoracic-esophagectomy group (95 percent confidence interval for the difference, -1 to 24 percent [the negative value indicates better survival with transhiatal resection]), whereas overall survival was 29 percent as compared with 39 percent (95 percent confidence interval for the difference, -3 to 23 percent).

CONCLUSIONS

Transhiatal esophagectomy was associated with lower morbidity than transthoracic esophagectomy with extended en bloc lymphadenectomy. Although median overall, disease-free, and quality-adjusted survival did not differ statistically between the groups, there was a trend toward improved long-term survival at five years with the extended transthoracic approach.

摘要

背景

关于食管癌的最佳手术治疗方法存在争议。

方法

我们将220例食管中下段腺癌或累及食管远端的贲门腺癌患者随机分为经裂孔食管切除术组或经胸食管切除术联合扩大整块淋巴结清扫术组。主要终点为总生存期和无病生存期。还确定了早期发病率和死亡率、获得的质量调整生命年数以及成本效益。

结果

共有106例患者被分配接受经裂孔食管切除术,114例接受经胸食管切除术。两组的人口统计学特征和肿瘤特征相似。经胸食管切除术后围手术期发病率较高,但住院死亡率无显著差异(P = 0.45)。中位随访4.7年后,142例患者死亡——经裂孔切除术后74例(70%),经胸切除术后68例(60%)(P = 0.12)。虽然生存差异无统计学意义,但扩大手术方式在五年时有生存获益的趋势:经裂孔食管切除术组的无病生存期为27%,经胸食管切除术组为39%(差异的95%置信区间为-1至24%[负值表明经裂孔切除术生存更好]),而总生存期分别为29%和39%(差异的95%置信区间为-3至23%)。

结论

与经胸食管切除术联合扩大整块淋巴结清扫术相比,经裂孔食管切除术的发病率较低。虽然两组的中位总生存期、无病生存期和质量调整生存期在统计学上没有差异,但扩大经胸手术方式在五年时有改善长期生存的趋势。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验